Dong-A Wins Approvals From Otsuka, GSK For Split Into Holding Company
This article was originally published in PharmAsia News
Executive Summary
Dong-A Pharmaceutical is pushing to create a favorable environment for a temporary shareholder meeting on Jan. 28, though the third-largest shareholder, the National Pension Service, is opposed to a proposal to float a holding company.
You may also be interested in...
Korea Allows Sales Of OTC Products In Supermarkets July 21, But Distribution Remains A Challenge
SEOUL - South Koreans are expected to be able to purchase 48 new over-the-counter products at supermarkets and conveniences stores, previously only available at pharmacies, beginning July 21, but consumers found that companies need more time to allow for the expanded distribution and manufacturing
Dong-A Enrolls GSK Korea General Manager On Board Of Directors; GSK Says Move Will Strengthen Alliance, Not Influence
SEOUL - Korea's leading pharma Dong-A Pharmaceutical Co. Ltd. placed GlaxoSmithKline PLC's Korea General Manager Kim Jin-ho on its nine-member board of directors in a follow-up action to GSK's acquisition of a 9.9% stake in Dong-A in May 2010
Korea's Health Ministry Gets In The Act To Generate Korean Innovation For U.S. Markets
SEOUL - South Korea's Ministry of Health and Welfare has selected 21 Korean pharmaceutical manufacturers and 17 medical equipment firms to support these companies in the development of globally competitive new drugs, marketing efforts and U.S. FDA approvals needed for their advancement into the U.S. market